Zobrazeno 1 - 10
of 282
pro vyhledávání: '"premature ovarian failure (POF)"'
Publikováno v:
Gynecological Endocrinology, Vol 40, Iss 1 (2024)
Premature ovarian insufficiency (POI) or premature ovarian failure (POF) is a multifactorial disorder occurring in reproductive-age women, characterized by elevated levels of follicle-stimulating hormone (FSH) and irregular or absent menstrual cycles
Externí odkaz:
https://doaj.org/article/a527b588e0884f9fab211cfcd800731b
Autor:
Bayalige, HAN Xia, YUN Sheng
Publikováno v:
Jichu yixue yu linchuang, Vol 43, Iss 12, Pp 1891-1895 (2023)
Premature ovarian failure (POF) is a gynecological endocrine disease caused by ovarian dysfunction. Mesenchymal stem cells (MSCs) can effectively treat premature ovarian failure, and play a role in repairing ovarian structure and improving ovarian fu
Externí odkaz:
https://doaj.org/article/2c98f96094d240e5a54024468ee8656e
Autor:
Singh, Akanksha a, b, Tripathi, Rupal a, b, Gupta, Rakesh Kumar a, Rashid, Rumaisa a, Jha, Rajesh Kumar a, b, 1, 2, ⁎
Publikováno v:
In Reproductive Biology June 2024 24(2)
Autor:
Krzysztof Grettka, Katarzyna Idzik, Katarzyna Lewandowska, Ksena Świętek, Simone Palini, Franco Silvestris
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1139 (2024)
Today, women’s infertility is considered a social disease in females, occurring not only as an effect of POF (premature ovarian failure) but also as CTRI (cancer treatment-related infertility) in oncologic patients. Several procedures for FP (ferti
Externí odkaz:
https://doaj.org/article/5b39c340441f4cd6bbed6135c952f6f4
Autor:
Ubba, Vaibhave a, Gupta, Rakesh Kumar a, Hakim, Bilal Ahmad a, Bora, Himangsu K. b, Sachdev, Monika a, Tripathi, Rupal a, Jha, Rajesh Kumar a, ⁎, 1
Publikováno v:
In Reproductive Biology June 2023 23(2)
Autor:
Eslami, Nasim a, b, c, 1, Bahrehbar, Khadijeh a, b, 1, Esfandiari, Fereshteh b, Shekari, Faezeh b, c, Hassani, Seyedeh-Nafiseh b, c, Nazari, Abdoreza b, Pakzad, Mohammad b, Baharvand, Hossein a, b, ⁎
Publikováno v:
In Life Sciences 15 May 2023 321
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Premature ovarian failure (POF) is an insidious cause of female infertility and a devastating condition for women. POF also has a strong familial and heterogeneous genetic background. Management of POF is complicated by the variable etiology and pres
Externí odkaz:
https://doaj.org/article/d199a05ef806485998106fa6f8737b36
Autor:
Gao, Mingming a, b, Yu, Zhaoer a, b, 1, Yao, Dan a, b, Qian, Yating a, Wang, Qi a, Jia, Ruizhe a, *
Publikováno v:
In Tissue and Cell February 2022 74
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectiveThe objective of this study was to compare the efficacy differences between Chinese patent medicines combined with hormone replacement therapy (HRT) in the treatment of premature ovarian failure (POF) by the Bayesian network meta-analysis (N
Externí odkaz:
https://doaj.org/article/22c2075ad2e44043b65097400a66de84
Autor:
Yuchi Zhang, Dongwei Han, Xiaoyan Yu, Xinyu Shao, Chuju Zong, Manyu Zhang, Junzhi Wang, Jingwen Liang, Pengling Ge
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
We previously screened 6 differentially expressed miRNAs in ovarian tissues of 4-vinylcyclohexene diepoxide (VCD)-treated premature ovarian failure (POF) model in SD rats, including miRNA-190a-5p, miRNA-98-5p, miRNA-29a-3p, miRNA-144-5p, miRNA-27b-3p
Externí odkaz:
https://doaj.org/article/6272bcc9c2d243efa2daa87eeb35951c